Results 11 to 20 of about 103,385 (306)

Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2015
Nodal peripheral T-cell lymphomas are a rare group of neoplasms derived from post-thymic and activated T lymphocytes. A review of scientific articles listed in PubMed, Lilacs, and the Cochrane Library databases was performed using the term "peripheral T ...
Luis Alberto de Pádua Covas Lage   +6 more
doaj   +1 more source

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas [PDF]

open access: yes, 2013
Obtained from Haematologica/the Hematology Journal website http://www.haematologica.orgPeripheral T-cell lymphomas are very aggressive hematologic malignancies for which there is no targeted therapy. New, rational approaches are necessary to improve the
Bischoff, James R.   +19 more
core   +2 more sources

Controlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture [PDF]

open access: yes, 2012
Peripheral T-cell lymphoma (PTCL) represents a relatively rare group of heterogeneous non-Hodgkin lymphomas, with generally poor prognosis. Historically, there has been a lack of consensus regarding appropriate therapeutic measures for the disease, with ...
Samantha L Semenkow   +3 more
core   +2 more sources

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features

open access: yesHaematologica, 2013
Peripheral T-cell lymphoma, not otherwise specified is a heterogeneous group of aggressive neoplasms with indistinct borders. By gene expression profiling we previously reported unsupervised clusters of peripheral T-cell lymphomas, not otherwise ...
Bettina Bisig   +9 more
doaj   +1 more source

A case of primary peripheral T-cell type non-Hodgkin lymphoma originating in the iris: Clinico-pathological findings [PDF]

open access: yes, 2010
Background. The ocular adnexal region is the primary localization of extranodal lymphoma in 5% to 15% of all Non-Hodgkin lymphoma. Intraocular lymphoma of T-cell origin is extremely rare and such sites of infiltration have been rarely observed in ...
Jaković Ljubomir   +6 more
core   +1 more source

Peripheral T-Cell Lymphomas [PDF]

open access: yesEgyptian Journal of Hematology and Bone Marrow Transplantation, 2016
Nodal peripheral T cell lymphomas (TCL) are rare entities with poor prognosis including ALK+ and ALK- systemic anaplastic T-cell lymphoma (ALCL), angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma – not otherwise specified. The role of PET in TCL is less well established compared to other lymphoma entities.
Maria K. Angelopoulou   +2 more
openaire   +2 more sources

Skeletal Muscle Peripheral T-Cell Lymphoma [PDF]

open access: bronzeJournal of Clinical Oncology, 2008
Todd J, Alekshun   +4 more
openaire   +3 more sources

Peripheral T-Cell Lymphoma not otherwise specified with oral manifestation: A Case Report.

open access: yesJournal of Oral Research, 2020
Peripheral T-Cell Lymphoma Not Otherwise Specified it is a rare type of Non-Hodgkin t-cells malignant tumor whose oral manifestations are difficult to diagnose.
Alvaro Vigouroux   +2 more
doaj   +1 more source

Peripheral T-cell lymphoma

open access: yesBlood, 2011
AbstractPeripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive diseases associated with poor outcome. Studies that focus specifically on PTCL are emerging, with the ultimate goal of improved understanding of disease biology and the development of more effective therapies.
Foss F. M.   +5 more
openaire   +4 more sources

Follicular variant of peripheral T-cell lymphoma

open access: yesIndian Journal of Pathology and Microbiology, 2017
Globally, peripheral T-cell lymphomas (PTCLs) constitute about 12% of all non-Hodgkin lymphomas, of which the unspecified category is the most common subtype (30%).
Archana Lakshmanan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy